Politics By Matthew Herper Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria
Politics By Rachel Cohrs Andrew Cuomo’s Covid-19 nursing home fiasco shows the ethical perils of pandemic policymaking
Politics By Nicholas Florko The questions Congress should ask Pfizer, Moderna, and Johnson & Johnson about the Covid-19 vaccines
Politics By Lev Facher States still can’t import drugs from Canada. Now, many are seeking to import Canadian prices
First Opinion By Lanhee J. Chen, Tom Church, and Daniel L. Heil A public option for health insurance could be a disaster, especially in times of crisis
Politics By Rachel Cohrs The Biden administration is making nursing schools pay for a government mistake amid Covid-19
First Opinion By William S. Smith The Biden administration needs to look beyond ICER for evaluating drug therapies
Politics By Nicholas Florko Woodcock vs. Sharfstein: A head-to-head comparison of Biden’s top choices for FDA commissioner
Special Report By Rachel Cohrs Hospitals’ Covid-19 heroics have them poised for power in the new Washington
First Opinion By Ed Schoonveld If 2021 is to be the year of U.S. drug price controls, how should biopharma companies respond?
Heavyweights By Lev Facher Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science
Politics By Nicholas Florko U.S. will have enough Covid-19 vaccines for 300 million Americans by end of summer, Biden says
Exclusive By Olivia Goldhill Undercounting of Covid-19 deaths is greatest in pro-Trump areas, analysis shows
Politics By Nicholas Florko Covid-19 vaccine supply is running low. Here’s how Biden hopes to fix that
Exclusive By Nicholas Florko and Lev Facher Longtime Becerra aide and two health policy experts to be tapped for key posts